Tema Oncology ETF (CANC) Holdings → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free CANC Stock Alerts $26.88 +0.31 (+1.17%) (As of 05/1/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartDividendHoldingsRatingsSocial MediaStock AnalysisChartDividendHoldingsRatingsSocial Media Top 49 CANC HoldingsRankCompanyCurrent PriceWeightShares Held1MRKMerck & Co., Inc.$128.99-0.2%5.52%7,6122REGNRegeneron Pharmaceuticals$898.62+0.9%5.52%1,0663Daiichi Sankyo Co LtdN/A3.84%22,5764AstraZeneca PLCN/A3.74%4,7605Novartis AG Registered SharesN/A3.59%6,6846ILMNIllumina$122.95-0.1%3.44%5,084 Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 7EXASExact Sciences$58.41-1.6%3.19%8,6778RVMDRevolution Medicines$37.60+0.9%3.19%15,3849ARGXargenx$382.93+2.0%2.89%1,39210GILDGilead Sciences$65.40+0.3%2.81%7,33411Chugai Pharmaceutical Co LtdN/A2.74%14,34812CLDXCelldex Therapeutics$38.60+3.2%2.66%11,91013BPMCBlueprint Medicines$92.89+1.7%2.64%5,13414CRSPCRISPR Therapeutics$52.96-0.1%2.44%7,48615BMYBristol-Myers Squibb$44.17+0.5%2.42%8,63816EXELExelixis$21.07-10.2%2.41%18,50317INCYIncyte$52.35+0.6%2.37%7,75218MREOMereo BioPharma Group$3.052.34%152,55019DAWNDay One Biopharmaceuticals$17.68+3.4%2.23%24,40320First American Treasury Obligs XN/A2.13%367,13121GMABGenmab A/S$28.11+1.5%2.02%12,30822MRNAModerna$109.38-0.8%1.98%3,35023Siemens Healthineers AG Registered SharesN/A1.98%6,27424LEGNLegend Biotech$42.55-2.7%1.93%7,08225BGNEBeiGene$155.22+0.8%1.92%2,51626GHGuardant Health$17.96-0.2%1.88%19,43827NTLAIntellia Therapeutics$22.08+3.2%1.79%14,48528MRUSMerus$46.07+2.6%1.74%7,41229SDGRSchrödinger$25.53+4.7%1.69%11,98730AGIOAgios Pharmaceuticals$33.47+3.0%1.66%9,72431DCPHDeciphera Pharmaceuticals$25.37+0.4%1.54%18,63332NUVLNuvalent$68.60-0.4%1.50%4,11733LNTHLantheus$67.66+1.7%1.46%4,04334OPCHOption Care Health$29.96+0.2%1.41%7,89135TXG10x Genomics$26.86-8.3%1.40%8,34136ARVNArvinas$31.64-0.4%1.40%7,07237SWTXSpringWorks Therapeutics$46.35-0.7%1.34%5,45038FUSNFusion Pharmaceuticals$21.52+0.4%1.28%10,40939IMCRImmunocore$59.10+0.0%1.25%3,94440CGEMCullinan Oncology$27.68+2.5%1.15%10,983Have You Seen Elon’s New A.I. Device? (Picture Inside) (Ad)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat...41RCUSArcus Biosciences$15.37+0.9%0.99%11,47742ACLXArcellx$51.31+2.6%0.96%3,05343RLAYRelay Therapeutics$6.55+0.5%0.81%22,78044COGTCogent Biosciences$6.76+4.0%0.70%18,30145IDYAIDEAYA Biosciences$40.84+0.5%0.70%3,19046FATEFate Therapeutics$3.99+1.0%0.58%19,82347PYXSPyxis Oncology$4.37-1.8%0.43%16,23848MRSNMersana Therapeutics$3.41+7.6%0.38%19,46549DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.05%174,092,005 Geographic ExposureUnited States78.4%Japan6.8%United Kingdom4.0%Switzerland3.6%Germany1.9%Canada1.2%Currency ExposureUSD83.7%JPY6.8%GBP4.0%CHF3.6%EUR1.9%Sector ExposureHealth Care70.6%Consumer Discretionary1.9%Industry ExposureBiotechnology57.2%Health Care Equipment & Supplies9.7%Pharmaceuticals3.6%Diversified Consumer Services1.9%SubIndustry ExposureBiotechnology47.2%Life Sciences Tools & Services6.3%Pharmaceuticals4.3%Health Care Equipment3.4%Coupon Exposure4-62.1%Maturity Exposure15-202.1% Related Companies and Tools Related Companies: Themes Generative Artificial Intelligence ETF Portfolio Companies Roundhill Video Games ETF Portfolio Companies Horizon Kinetics SPAC Active ETF Portfolio Companies Relative Sentiment Tactical Allocation ETF Portfolio Companies iShares Transition-Enabling Metals ETF Portfolio Companies Global X Thematic Growth ETF Portfolio Companies Fidelity Crypto Industry and Digital Payments ETF Portfolio Companies iShares Emerging Markets Infrastructure ETF Portfolio Companies BNY Mellon Innovators ETF Portfolio Companies Proshares Equities For Rising Rates ETF Portfolio Companies This page (NASDAQ:CANC) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyAI “wealth window” is closing June 25thParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
